Oppenheimer & CO Inc Veru Inc. Transaction History
Oppenheimer & CO Inc
- $6.43 Billion
- Q1 2025
A detailed history of Oppenheimer & CO Inc transactions in Veru Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 1,325,246 shares of VERU stock, worth $675,875. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,325,246
Previous 1,120,586
18.26%
Holding current value
$675,875
Previous $728,000
10.85%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding VERU
# of Institutions
138Shares Held
56MCall Options Held
817KPut Options Held
595K-
Black Rock Inc. New York, NY7.65MShares$3.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY6.48MShares$3.31 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.25MShares$3.19 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.29MShares$2.19 Million0.42% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.76MShares$1.92 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $40.9M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....